what does company need to do?

I check VIT 1st half results
not bad.
VD&S was a standout, and obviously is the main reason to hold the share.
EBIT was up 77%. Sales up significantly. margins well up(adjusted for FX- fx no issue now ,as AUD has improved)
these are solid 1st results for a new company

breaking down geographics, domestically very good, and China up a lot off a low base(nutralife brand). Middle east Vitamins also saw 67% increase or so(they got contract with a retailer there) and middle east has a growing love of australian products. Vitaco's products are of high quality.

New regions are also a possibility longer term. Doesnt have to be all china. Emerging markets population is ~3billion.

Main negative - trilogy nz only contract loss 1.5M EBITDA. but this only affects FY17, and other initiatives above, launch of skin care own brand, acquisition etc will neutralise it.

Valuation, is not demanding. At current levels less than 15x assuming above trends intact. This is TLS's p/e ratio. Dividend is fine around 3.5% fully franked, 55% payout ratio based on prospectus eps of 11 cents. yield looks well above average for a growth stock. Most growth shares have yields of around 2%, some have no dividend at all.

Most ASX company report every 6 months. I guess between now and then a few presentations and new product updates can be tried to help improve it.